Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
(Carolyn Kaster / AP)
Senators on the Health, Education, Labor and Pensions Committee used a drug user fee reauthorization markup as a platform for discussing bigger health care fights, including prescription drug prices and the GOP's health reform effort. And yes, they approved the bill to renew the user fees that help fund the Food and Drug Administration — so relax, FDA.
Read on for the highlights.
- The user fee bill passed 21-2.
- A bipartisan amendment focused on increasing generic drug competition, authored by Sens. Susan Collins and Al Franken, also passed unanimously.
- An amendment by Sen. Bernie Sanders that would allow drugs to be imported from Canada was tabled after extensive debate throughout the hearing.
- Some Democrats made personal appeals to Chairman Lamar Alexander to include them in health reform efforts. Franken, a Democrat, said problems with Affordable Care Act exchanges and prescription drug costs are "the two glaring issues" facing the committee. "You have been someone who believes in working in a bipartisan way to solve problems," Franken said directly to Alexander. "If we do not have an overall working health care system in which to do these things, much of the discussion today is irrelevant," said Sen. Maggie Hassan, after discussing the opioid crisis and prescription drug costs.